Authors

  • John Wilkinson

DOI:

https://doi.org/10.5912/jcb426

Abstract

Presents updates on legal and regulatory issues concerning biotechnology and the pharmaceuticals industry in Europe as of September 2001. Proposals of the European Commission for changes in the Community pharmaceuticals legislation; Medications labeled as an Orphan Drug; Directives in biotechnological intellectual property.

Downloads